PHAT
Phathom Pharmaceuticals Inc
7.50$
-3.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +28,412.0% | +14.7% | -35.8% | -13.0% | +151.1% | -8.6% | -31.5% | |
| – | +28,237.1% | +14.0% | -36.0% | -13.9% | +147.6% | -9.4% | -36.4% | |
| – | +27,632.1% | +17.9% | -36.3% | -15.2% | +145.5% | -22.1% | -56.3% | |
| – | +27,632.1% | +17.9% | -36.3% | -15.2% | +145.5% | -22.1% | -56.3% | |
| – | – | – | – | – | – | +2,270.0% | +101.4% | |
| – | – | – | – | – | – | +165.6% | +72.0% | |
| – | – | +140.6% | -80.6% | +437.5% | – | – | – | |
| – | +1,235.6% | +245.1% | +16.3% | +104.3% | +103.1% | +29.9% | +10.4% | |
| – | +71.3% | +1,381.4% | -65.9% | +38.7% | +47.8% | +121.1% | +54.0% | |
| – | -91.7% | +4,761.5% | -93.8% | +45.4% | +2.5% | -31.0% | +29.3% | |
| – | +1,170.9% | +2,300.9% | -69.3% | +94.1% | +26.0% | -16.6% | -52.6% | |
| – | – | +74.0% | +126.2% | +6.2% | +44.7% | +46.1% | +3.8% | |
| – | – | -14.8% | -62.9% | -203.7% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +188.3% | +34.4% | +11.4% | +5.7% | +31.1% | +23.2% | +15.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.